Form D · Pharmaceuticals
PridCor Therapeutics, LLC
Tuscaloosa, AL · CIK 0002074593
Offering snapshot reported Jul 6, 2026 · SEC filing
- Reported sold
- Yet to sell Offering amount: $6.05M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 6, 2026 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| May 8, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 2, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 25, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-583403
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| NA | None |
Source: Form D, filed Jul 6, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Corday | Executive, Promoter |
| William L Pridgen | Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1837 Commons North Drive
Tuscaloosa, AL, 35406
Phone: 2053660696
Tuscaloosa, AL, 35406
Phone: 2053660696